Evidence map›Paper›PMID 25246615›Full record

ArticleThe Journal of cell biology2014

Mastl is required for timely activation of APC/C in meiosis I and Cdk1 reactivation in meiosis II.

Deepak Adhikari, M Kasim Diril, Kiran Busayavalasa, Sanjiv Risal, Shoma Nakagawa, Rebecca Lindkvist, Yan Shen, Vincenzo Coppola, Lino Tessarollo, Nobuaki R Kudo and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. MPF-based meiotic cell cycle control: Half a century of lessons from starfish oocytes.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2018
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Deepak AdhikariDepartment of Chemistry and Molecular Biology, University of Gothenburg, S-405 30 Gothenburg, Sweden.
M Kasim DirilInstitute of Molecular and Cell Biology, A*STAR, Singapore 138673, Republic of Singapore.
Kiran BusayavalasaDepartment of Chemistry and Molecular Biology, University of Gothenburg, S-405 30 Gothenburg, Sweden.
Sanjiv RisalDepartment of Chemistry and Molecular Biology, University of Gothenburg, S-405 30 Gothenburg, Sweden.
Shoma NakagawaInstitute of Reproductive and Developmental Biology, Department of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London W12 0NN, England, UK.
Rebecca LindkvistDepartment of Chemistry and Molecular Biology, University of Gothenburg, S-405 30 Gothenburg, Sweden.
Yan ShenDepartment of Chemistry and Molecular Biology, University of Gothenburg, S-405 30 Gothenburg, Sweden.
Vincenzo CoppolaNational Cancer Institute, Mouse Cancer Genetics Program, National Cancer Institute-Frederick, Frederick, MD 21702.
Lino TessarolloNational Cancer Institute, Mouse Cancer Genetics Program, National Cancer Institute-Frederick, Frederick, MD 21702.
Nobuaki R KudoInstitute of Reproductive and Developmental Biology, Department of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London W12 0NN, England, UK.
Philipp KaldisInstitute of Molecular and Cell Biology, A*STAR, Singapore 138673, Republic of Singapore Department of Biochemistry, National University of Singapore, Singapore 117599, Republic of Singapore kaldis@imcb.a-star.edu.sg kui.liu@gu.se.
Kui LiuDepartment of Chemistry and Molecular Biology, University of Gothenburg, S-405 30 Gothenburg, Sweden kaldis@imcb.a-star.edu.sg kui.liu@gu.se.
University of Gothenburg · SEImperial College London · GBInstitute of Molecular and Cell Biology · SGNational Cancer Institute · US

Funding

Medical Research Council G0901046
6 · The paper itself

Abstract

In mitosis, the Greatwall kinase (called microtubule-associated serine/threonine kinase like [Mastl] in mammals) is essential for prometaphase entry or progression by suppressing protein phosphatase 2A (PP2A) activity. PP2A suppression in turn leads to high levels of Cdk1 substrate phosphorylation. We have used a mouse model with an oocyte-specific deletion of Mastl to show that Mastl-null oocytes resume meiosis I and reach metaphase I normally but that the onset and completion of anaphase I are delayed. Moreover, after the completion of meiosis I, Mastl-null oocytes failed to enter meiosis II (MII) because they reassembled a nuclear structure containing decondensed chromatin. Our results show that Mastl is required for the timely activation of anaphase-promoting complex/cyclosome to allow meiosis I exit and for the rapid rise of Cdk1 activity that is needed for the entry into MII in mouse oocytes.

Indexed as

MeiosisAnaphaseAnaphase-Promoting Complex-CyclosomeAnimalsCDC2 Protein KinaseEnzyme InductionFemaleHEK293 CellsHumansMaleMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutMicroscopy, FluorescenceMicrotubule-Associated ProteinsAnaphase-Promoting Complex-CyclosomeCDC2 Protein Kinasegreatwall protein, mouseMicrotubule-Associated ProteinsProtein Phosphatase 2Protein Serine-Threonine Kinases

Identifiers

PMID25246615
PMCPMC4178961
OpenAlexW2160825701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.